Revvity | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
Adcock Ingram Holdings ZAR 1.61B 802K 2024-06
Agilent USD 899M 18M 2025-01
Align Technology USD 696.94M 15.17M 2024-12
Bio Techne USD 196.58M 8.66M 2024-12
Bio-Rad Laboratories USD 355.1M 803K 2024-12
Bruker USD 493.3M 74.5M 2024-12
Celltrion KRW 463.41B 95.59B 2024-09
Charles River Laboratories USD 319.68M 48.09M 2024-12
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Danaher USD 3.89B 489M 2024-12
Dentsply International USD 455M 40M 2024-12
Ecofibre AUD 2.08M 4.33M 2024-06
Edwards Lifesciences USD 1.09B 2.1M 2024-12
Exact Sciences USD 429.29M 83.29M 2024-12
Hologic USD 580.5M 22.8M 2024-12
Illumina USD 728M 17M 2024-12
Intuitive Surgical USD 1.64B 268.3M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Laboratory Of America USD 896.3M 8.1M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 13.36M 2.36M 2024-06
Mettler Toledo International USD 639.31M 66.85M 2024-12
Myriad Genetics USD 150.9M 1.1M 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Patterson Companies USD 320.82M 7.27M 2025-01
Pharma Mar EUR 47.05M 3.4M 2024-12
Qiagen NV USD 349.8M 19.17M 2024-12
Quest Diagnostics USD 858M 42M 2024-12
Quidel USD 326.1M 26.2M 2024-12
Repligen USD 77.49M 220K 2024-09
Revvity USD 412.29M 27.47M 2024-12
Sartorius EUR 345.1M 43.2M 2024-09
Sino Biopharmaceutical CNY 10.5B 3.99B 2024-12
Thermo Fisher Scientific USD 4.82B 494M 2024-12
Tilray USD 61.22M 1.51M 2024-11
Waters USD 524.2M 85.55M 2024-12
Zz Pientze Pharmaceu 1.29B 268M 2024-09



Revvity Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.